NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards

The summary for the NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the advanced stage development of pharmacological treatment agents for drug and nicotine abuse and dependence. This FOA specifically invites applications for the competing renewal (formerly competing continuation ) of previously funded Phase II SBIR grants, to take existing, promising compounds through the next step of drug discovery and development.
Federal Grant Title: NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-036
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Dec 08, 2005
Creation Date: Jan 26, 2009
Archive Date: Oct 02, 2009
Total Program Funding:
Maximum Federal Grant Award: $750,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award for both Phase I and Phase II SBIR awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the U.S. economy, and is organized for profit. 2. Is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or (b) for SBIR only, it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent re! sident aliens, in the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in Title 13 Code of Federal Regulations (CFR) Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 CFR 121.103. The term "number of employees" is defined in 13 CFR 121.106 -- Small Business Size Regulations. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtaine! d at http://sba.gov/size, or by contacting the Small Business Administ ration's (SBA) Government Contracting Area Office or Office of Size Standards.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

NIH OER Webmaster [[email protected]]
Similar Government Grants
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not ...
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
Prescription Drug Abuse
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com